Company / R&D per Share
Oruka Therapeutics, Inc. R&D per Share History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$4.47
FY2024
5-year range
$0.07 / $4.47
FY2020-FY2024
Trend
+6259.6%
vs FY2023
Sector context
#43 of 208
Health Care
What the data says
R&D per Share changed +6260% YoY in FY2024, a notable deviation from the 9-year average annual change of +720%.
Based on SEC 10-K filings.
4.47 in FY2024 with a 5-year CAGR of -4.0%. Top quartile in the Health Care sector.
Improved from $0.96 to $4.47 over the past 2 years.
Health Care sector context is included.
R&D per Share over time
Growth rates
- 3-Year CAGR
- +104.5%
- 5-Year CAGR
- -4.0%
- 10-Year CAGR
- -
Sector benchmark
Top 21% in Health CareTop 21% of 208This company $4.47 Sector average $12.19
▼
-63.3% below sector average
Key checks
Key Insights
- In FY2024, r&d per share increased 6259.6% year-over-year.
- Ranks #43 out of 208 companies in the Health Care sector.
- Peak r&d per share was recorded in FY2019.
- Lowest r&d per share in the period was in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $4.47 | +6259.6% |
| FY2023 | $0.07 | -92.7% |
| FY2022 | $0.96 | +83.6% |
| FY2021 | $0.52 | -54.5% |
| FY2020 | $1.15 | -79.0% |
| FY2019 | $5.48 | +358.4% |
| FY2018 | $1.20 | -12.1% |
| FY2017 | $1.36 | +74.2% |
| FY2016 | $0.78 | -58.1% |
| FY2015 | $1.86 | +897.3% |
As of FY2024 · SEC 10-K · Updated Jun 30, 2026